Episode
E22: Noradrenergic and Specific Serotonergic Antidepressant: Mirtazapine (Remeron)
- Published
- Jan 14, 2025
- Duration seconds
- 3093
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/episodes/e22-noradrenergic-and-specific-serotonergic-antidepressant-mirtazapine-remeron/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/e22-noradrenergic-and-specific-serotonergic-antidepressant-mirtazapine-remeron.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Today I'm talking about mirtazapine, which is in a class of its own as both a noradrenergic and selective serotonergic antidepressant and a tetracyclic antidepressant. It has some very unique qualities that make it a great pick for some patients, and its the only option when you need this unique combination of characteristics. I use this one from time to time but not too frequently because of the weight gain adverse effect. But mirtazapine is more than just an antidepressant that causes weight gain and sedation. Tune in to find out.